Abstract
Guidelines recommend cytology screening of cervical cancer every 3-years starting at the age 21 to 29 years. For age 30 onwards primary human papillomavirus (HPV) testing or co-testing (HPV + cytology) is also recommended every 5-years through age 65. The objective of the current review is to summarise the model-based cervical cancer screening studies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
